Late-Breaking Oral Abstract
Immunosuppression and Immune Monitoring 

Wednesday August 06, 2025 | 10:00 to 11:15
Room: 25
Track: Allied Health

Presentations

Rajalingam Raja, United States
Desensitization with CD38 Monoclonal Antibody and CTLA4-Ig Enables Transplantation in Highly Sensitized Kidney Candidates with CPRA ≥99.9%

Nader Abraham, United States
C5aR1 Inhibition Ameliorates DGF in a DCD Porcine Kidney Auto-Transplantation Model

Zhao Feng LIU, People's Republic of China
Mechanism Study of Tacrolimus Inhibiting FXR Mediated Toxicity of Renal Tubular Epithelial Cells

Romain Brousse, France
Liquid-Biopsy Risk Assessment Versus Invasive Surveillance in Kidney Transplant: a Randomized Controlled Trial

Marta Crespo, Spain
First Year Pre-transplant Immunobiogram (IMBG) Predictability of de novo Rejection or Infection after 3 months in Biotraim Study

Ekkehard Schuetz, United States
Combining Percentage and Concentration of dd-cfDNA in Kidney Transplantation is Highly Sensitive and Specific for Rejections. Results from Five Clinical Cohort

Tasha Kalista, United States
Analytical and Clinical Validation of TransplantTrace cfDNA Test

Katerina Hysi, United States
Donor-derived cell-free DNA (dd-cfDNA) trends in adult kidney transplant recipients with cytomegalovirus (CMV) viremia

Email: info@wtc2025.org
514-874-1717